News on NASH

Video Courtesy of The NASH Education Program™



Click here for a brief synopsis. Video Courtesy of Pinnacle Clinical Research and AASLD TV


Experts raise red flag over fatty liver disease

Date: 24 Oct 2017

Story by MedPage Today.

Rinella noted that the number of liver transplants owing to advanced NASH has risen 68% in the past decade, while the number of available organs has only risen 11%. And the number of people with NASH on transplant waiting lists is expected to grow 55.4% by 2030, she added.

Read More

A common herbal medicine may cause liver cancer mutations

Date: 18 Oct 2017

Story by New Scientist.

Extracts taken from plants of the genus Aristolochia, which are used in traditional Chinese medicine to treat a wide range of conditions, may be responsible for many liver cancers in Asia.

Read More

Can Taurine and polyphenols help treat fatty liver disease?

Date: 17 Oct 2017

Story by Medical News Bulletin.

Taurine, an amino acid, is believed to have effects on levels of blood glucose, lipids, and liver transaminases. Polyphenols are the natural compounds found in tea and are often used as natural antioxidants. The combination of taurine and tea polyphenols might reveal a possible treatment in addition to changes in diet and lifestyle for fatty liver disease, specifically NASH.

Read More

Liver disease risk may be heightened by gastric acid drugs

Date: 10 Oct 2017

Story by Medical News Today.

Researchers found that proton pump inhibitors, which are drugs used to reduce gastric acid, could promote the growth of a type of bacteria associated with chronic liver diseases.

Read More

NASH: Pointers for Pharma from the Patient's Perspective

Date: 03 Oct 2017

Story by

The disease was first identified in the 1980s. Since then, its prevalence has grown rapidly in line with that of NAFLD, now one of the most common liver diseases worldwide. These trends reflect a growing epidemic of type 2 diabetes and obesity worldwide. One recent meta-analysis found the global prevalence of NAFLD to be around 25%, while the global prevalence of NASH is estimated at 3-5%.

Read More

Combinations of PACS and AI helps uncover what radiologists...

Date: 22 Sep 2017

Story by Healthcare IT News.

“A key benefit is that the AI software searches certain imaging studies for several specific conditions,” Gaskin explained. “It calculates liver density from a CT chest or abdomen study to detect a fatty liver, identifies emphysema by detecting levels of trapped air in the lungs from a CT chest study, and determines levels of coronary calcium from non-contrast CT chest studies, in addition to assessing bone density.”

Read More

Do you have diabetes, liver disease? Watch out for CVD

Date: 13 Sep 2017

Story by Medical News Today.

A study analyzing the medical data of more than 133,000 people shows that those with diabetes and a medical history of non-alcoholic fatty liver disease have a significantly higher risk of cardiovascular disease and mortality.

Read More

Demand for liver transplant for NASH set to continue rising

Date: 24 Aug 2017

Story by Medical Xpress.

Given population obesity trends, the increase in the demand for liver transplantation (LT) for nonalcoholic steatohepatitis (NASH) noted since 2000 is expected to continue, according to a study published online Aug. 17 in Hepatology.

Read More

Low thyroid function predicts NASH, fibrosis in patients wit...

Date: 21 Aug 2017

Story by Healio.

“The prevalence of NASH and advanced fibrosis associated with [thyroid-stimulating hormone levels] was significantly higher in subjects with subclinical hypothyroidism than in those with normal thyroid function,” the researchers wrote.

Read More

NASH Biomarkers Market Analysis by Type, End-use and Segment...

Date: 21 Aug 2017

Read the article here.

The global non-alcoholic steatohepatitis (NASH) biomarkers market is expected to reach USD 2.09 billion by 2025, according to a new report by Grand View Research, Inc.

Read More

1 ... 3 4 5 6 7